Diversity Program
Designing trials that reflect real-world populations is increasingly difficult amid complex protocols, decentralized models, and site capacity constraints.
The Medidata Diversity Program provides a connected set of solutions to help sponsors support diversity from study design through execution.
Easily Enroll the Patients Your Therapy Is Meant to Serve
Despite clear diversity goals, sponsors often struggle to reach and enroll underrepresented patients due to protocol burden, site constraints, and fragmented patient engagement.
The Medidata Diversity Program aligns patient, site, and sponsor experiences to reduce participation barriers and support more representative enrollment.
Flexible Participation Models
Patient‑informed Design
Sustained Patient Engagement
Data-driven
Site Selection
Multiple Paths to More Representative Enrollment
De-Risk Enrollment
Medidata Study Feasibility
When selecting sites, you need confidence they can both operate effectively and enroll diverse patient populations.
Medidata Study Feasibility helps you use industry-wide, site-level data to choose sites with a proven track record—supporting realistic diversity goals and fewer enrollment delays.
Featured Resource
The State of Black Participation in Clinical Trials
This analysis reveals where Black enrollment aligns with U.S. Census benchmarks and where gaps remain. National averages can hide meaningful differences by therapeutic area and site. See how granular data can strengthen diversity planning.
Download White Paper
FAQ
Can the Medidata Diversity Program help us comply with the FDA’s Diversity Action Plans?
Yes. The program is purpose-built to help clinical teams meet diversity goals and comply with regulatory guidance, including the FDA’s Diversity Action Plans. It empowers you to create data-driven plans by combining site-level demographic data, real-time enrollment monitoring, and community engagement capabilities.
How does the solution assist with site selection for diversity?
The program allows you to confidently select high-performing sites using industry-wide, site-level data. You can benchmark against the industry and identify sites that have a proven historical track record of successfully enrolling diverse patient populations, ensuring you meet your specific enrollment targets.
Does the program include mechanisms to incorporate patient feedback into the study design?
Yes. You can actively infuse diverse patient voices into your protocol design by testing trial materials and protocols with diverse patient advocates and experts before the trial launches. This "Patient Centricity by Design" approach helps minimize burden and enhances the trial journey to enable broader participation.
Can we access a network of sites that serve underrepresented populations?
Yes. Through the program, you gain access to a patient-accessible site network—spanning traditional, hybrid, and decentralized models—that is specifically positioned to serve underrepresented communities. These sites, available through partnerships like Circuit Clinical, are trained on Medidata’s technologies to ensure they are research-ready.
Does Medidata offer training for its clients and partners?
Yes. Medidata offers a variety of training options for our clients and partners, including both self-paced and instructor-led courses. To learn more about available courses and to access our resources, please visit the Medidata Global Education and Training section.